In EP 204 of #TheGeneticsPodcast, Prof. @sripatti.bsky.social, director of @fimm-uh.bsky.social, discusses how FinnGen’s data are helping translate genetics into real-world clinical tools, such as polygenic risk scores & treatment prediction.
🎙️ pod.fo/e/328c49
In EP 204 of #TheGeneticsPodcast, Prof. @sripatti.bsky.social, director of @fimm-uh.bsky.social, discusses how FinnGen’s data are helping translate genetics into real-world clinical tools, such as polygenic risk scores & treatment prediction.
🎙️ pod.fo/e/328c49
Loss of CFHR5 function reduces the risk for age-related macular degeneration.
Nature Communications @natcomms.nature.com
🔗 doi.org/10.1038/s414...
Loss of CFHR5 function reduces the risk for age-related macular degeneration.
Nature Communications @natcomms.nature.com
🔗 doi.org/10.1038/s414...
We estimated missing intelligence test scores in @ukbiobank.bsky.social to reduce bias and boost power.
Preprint: www.medrxiv.org/content/10.1...
Thread 👇
We estimated missing intelligence test scores in @ukbiobank.bsky.social to reduce bias and boost power.
Preprint: www.medrxiv.org/content/10.1...
Thread 👇
www.nature.com/articles/s41... @naturemedicine.bsky.social
www.nature.com/articles/s41... @naturemedicine.bsky.social
www.cell.com/hgg-advances...
www.cell.com/hgg-advances...
nature.com/articles/s41... open-access
nature.com/articles/s41... open-access
That is the far harder road — taking more time and resources than going after well-trodden biology.
But Koller has some strong thoughts on why it's a worthwhile challenge:
That is the far harder road — taking more time and resources than going after well-trodden biology.
But Koller has some strong thoughts on why it's a worthwhile challenge:
CEO Daphne Koller shared with me the biotech's first progress update on a 2020 Bristol Myers collab on ALS & dementia.
More details here in my latest for @endpts.com:
endpts.com/exclusive-in...
CEO Daphne Koller shared with me the biotech's first progress update on a 2020 Bristol Myers collab on ALS & dementia.
More details here in my latest for @endpts.com:
endpts.com/exclusive-in...
Our study published today on #bioRxiv describe the identification of a deaminase that converts 5mC to T, enabling direct sequencing of the human methylome and genome. This achievement was made possible through a collaborative effort across all departments at #NEB.